摘要 |
<p>The invention concerns pharmaceutical compositions for oral administration containing 0.5 % to 20 % of N-piperidino-5- (4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide in microcrystalline form and pharmaceutical vehicles. The compositions are formulated by wet granulation.</p> |